Skip to main content
Premium Trial:

Request an Annual Quote

Clongen Laboratories Forms Separate Clinical Dx, Contract Research Branches

Premium

Clongen Laboratories, a Maryland-based CLIA-licensed testing facility, said this week that it has recently formed separate divisions for clinical diagnostics and contract research services.

Clongen's clinical diagnostics division specializes in screening a wide range of infectious diseases, primarily using real-time PCR. The Germantown-based company has historically focused on testing for tick-borne illnesses, but said that it also now offers more than 250 infectious disease assays, some of which are not offered anywhere else in the US.

The company's contract research services division offers a wide range of assays under GLP and GMP conditions to pharmaceutical, biotechnology, government, and academic institutions, the company said.

Services in this division include sterility testing, Mycoplasma detection and elimination, and endotoxin testing and removal. Clongen said that it has also recently developed rapid real-time PCR-based assays to detect all biowarfare select agents listed by the US Centers for Disease Control and Prevention.

Clongen said that it expects to soon receive CLIA licensure in five additional states beyond Maryland, and that it is establishing satellite facilities in several other states.

Founded in 1999 in Mountain View, Calif., as a biotechnology business consulting firm, Clongen established its Germantown laboratories in 2004 for clinical diagnostic testing.

Filed under

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.